Kirkland, WA, United States of America

Dmitri Sergueev


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dmitri Sergueev: Innovator in Viral Disease Treatment

Introduction

Dmitri Sergueev, an inventive mind based in Kirkland, Washington, has made significant contributions in the field of medicine through his innovations. With a focus on developing compounds for the treatment of viral diseases and cancer, he has patented a groundbreaking solution that showcases his dedication and expertise.

Latest Patents

Dmitri holds a patent for "1,3,5-triazines for treatment of viral diseases." This invention presents a novel class of compounds that are designed to effectively tackle viral infections and combat cancer. The implications of this patent could lead to advancements in therapeutic strategies and improved patient outcomes.

Career Highlights

Sergueev is affiliated with the company "1,3,5-triazines for Treatment of Viral Diseases," where his research and innovative spirit drive forward the organization's mission. His active involvement in this specialized field highlights his commitment to transforming healthcare through innovative treatments.

Collaborations

Throughout his career, Dmitri has collaborated with talented professionals such as Richard Daifuku and Alexander A Gall. These partnerships have fostered a dynamic environment for innovation, leading to the development of effective solutions in the realm of viral disease treatment.

Conclusion

Dmitri Sergueev stands out as a prominent inventor whose work addresses critical health challenges. His patent on 1,3,5-triazines illustrates the importance of innovation in medicine and the potential for new treatments to emerge through dedicated research and collaboration. As he continues to work alongside esteemed colleagues, the future looks promising for advancements in the battle against viral diseases and cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…